Andreas Hilbig

A randomized trial in patients with gemcitabine refractory pancreatic cancer. Final results of the CONKO 003 study

Uwe Pelzer, Krystian Kubica, Jens Stieler et al. · Journal of Clinical Oncology · 2008 · 126 citations

Medicine, Oncology, Pharmacology +12

Whole-organ perfusion of the pancreas using dynamic volume CT in patients with primary pancreas carcinoma: acquisition technique, post-processing and initial results

Sonja Kandel, Christian Kloeters, Henning Meyer et al. · European Radiology · 2009 · 107 citations

Medicine, Oncology, Radiology +15

Oxaliplatin/folinic acid/5-fluorouracil [24h] (OFF) plus best supportive care versus best supportive care alone (BSC) in second-line therapy of gemcitabine-refractory advanced pancreatic cancer (CONKO 003)

Helmut Oettle, Uwe Pelzer, Jens Stieler et al. · Journal of Clinical Oncology · 2005 · 97 citations

Medicine, Oncology, Pharmacotherapy +15

Rationale and design of PROSPECT-CONKO 004: a prospective, randomized trial of simultaneous pancreatic cancer treatment with enoxaparin and chemotherapy)

Hanno Riess, Uwe Pelzer, Andreas Hilbig et al. · BMC Cancer · 2008 · 81 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Continuous Endothelial Cell Activation Increases Angiogenesis: Evidence for the Direct Role of Endothelium Linking Angiogenesis and Inflammation

Rajashekhar Gangaraju, Antje Willuweit, Carolyn E. Patterson et al. · Journal of Vascular Research · 2006 · 71 citations · Full text

Life Sciences, Cell Biology, Immunology +17